IRIS
DUMINUCO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.323
AS - Asia 1.152
EU - Europa 760
AF - Africa 208
SA - Sud America 151
OC - Oceania 4
Totale 3.598
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.287
IT - Italia 515
SG - Singapore 494
CN - Cina 425
CI - Costa d'Avorio 146
BR - Brasile 127
KR - Corea 116
IE - Irlanda 52
VN - Vietnam 43
RU - Federazione Russa 39
FI - Finlandia 28
IN - India 26
GB - Regno Unito 25
BJ - Benin 21
SN - Senegal 20
MX - Messico 16
PL - Polonia 16
CA - Canada 15
DE - Germania 14
HK - Hong Kong 12
NL - Olanda 12
SE - Svezia 12
AR - Argentina 11
ZA - Sudafrica 11
BD - Bangladesh 10
UA - Ucraina 9
BE - Belgio 8
FR - Francia 8
CZ - Repubblica Ceca 7
ES - Italia 7
JP - Giappone 7
IQ - Iraq 6
VE - Venezuela 5
AU - Australia 4
NG - Nigeria 4
KE - Kenya 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
CO - Colombia 2
EC - Ecuador 2
GT - Guatemala 2
PK - Pakistan 2
PY - Paraguay 2
BF - Burkina Faso 1
BH - Bahrain 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
JO - Giordania 1
LB - Libano 1
LT - Lituania 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SO - Somalia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 3.598
Salva come PNG Salva come JPEG
Città #
Dallas 345
Singapore 307
Hefei 236
Santa Clara 235
Abidjan 146
Seoul 116
Chicago 114
Ashburn 99
Catania 84
Los Angeles 73
Beijing 51
Dublin 50
Civitanova Marche 48
Chandler 43
Boardman 38
Rome 37
Milan 36
Palermo 35
Buffalo 25
Cotonou 21
Dakar 20
Moscow 18
Warsaw 16
Ho Chi Minh City 15
Lappeenranta 14
New York 14
São Paulo 13
Florence 12
Hong Kong 12
Bari 11
Johannesburg 10
Chennai 9
Helsinki 9
Misterbianco 9
Stockholm 9
Amsterdam 8
Bronte 8
Brussels 8
Hanoi 8
Messina 8
Montreal 8
Munich 8
Rio de Janeiro 8
Turin 8
Boston 7
Naples 7
Phoenix 7
Tokyo 7
Washington 7
Cambridge 6
Denver 6
Lawrence 6
Manchester 6
Mexico City 6
Seattle 6
Belo Horizonte 5
Cassano delle Murge 5
London 5
Paris 5
Piazzola Sul Brenta 5
San Francisco 5
San Giovanni la Punta 5
Turku 5
Abuja 4
Atlanta 4
Brno 4
Frankfurt am Main 4
Genoa 4
Aci Sant'Antonio 3
Brooklyn 3
Bắc Ninh 3
Campinas 3
Curitiba 3
Lamezia Terme 3
Melbourne 3
Militello in Val di Catania 3
Mumbai 3
Nairobi 3
Olomouc 3
Piacenza 3
Pittsburgh 3
Poplar 3
Porto Alegre 3
Pozzallo 3
Santa Venerina 3
Örebro 3
Acireale 2
Ancona 2
Andover 2
Annapolis 2
Augusta 2
Birigui 2
Bologna 2
Can Tho 2
Caselle Torinese 2
Cernusco sul Naviglio 2
City of London 2
Cornaredo 2
Council Bluffs 2
Criciúma 2
Totale 2.615
Salva come PNG Salva come JPEG
Nome #
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 141
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 127
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 126
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 125
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 118
A case of high-risk AML in a patient with advanced systemic mastocytosis 112
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients 109
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 100
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 98
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 98
Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology 94
Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field 94
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study 93
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project 89
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 89
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 89
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases 88
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 87
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study 86
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 86
AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib 84
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 84
Leishmania Infection during Ruxolitinib Treatment: The Cytokines-Based Immune Response in the Setting of Immunocompromised Patients 83
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 83
Renal extramedullary hematopoiesis as an epiphenomenon of bone marrow dysfunction in a patient with primary myelofibrosis: A rare case report 83
Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters 78
VEXAS-like syndrome: a potential new entity? 75
Multicentric Castleman disease and concurrent hematological disorders: the occurrence of plasmacytoma and the hypotheses arising from literature's review 74
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 71
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes 71
Emergencies in Hematology: Why, When and How I Treat? 69
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases 67
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy 65
Emerging Therapeutic Approaches for Anemia in Myelofibrosis 65
Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association 62
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease 59
Transient Leukemoid Reaction from T-Cell Large Granular Lymphocytes Post Autologous Stem Cell Transplant in a Patient Affected by Hodgkin Lymphoma 58
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 57
Chemotherapy extravasation: diagnosis, prevention and management 52
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey 52
Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point? 49
Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms 46
Myelofibrosis: In Search for BETter Targeted Therapies 44
Clinical outcomes of ruxolitinib treatment in 595 intermediate‐1 risk patients with myelofibrosis: The RUX‐MF Real‐World Study 37
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib 30
Totale 3.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.841
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202252 0 0 0 0 6 4 3 1 6 14 5 13
2022/2023230 7 15 5 12 12 20 7 43 51 14 34 10
2023/2024474 26 60 22 55 13 88 33 36 6 17 80 38
2024/20251.189 16 174 41 114 190 121 60 45 71 85 123 149
2025/20261.702 226 425 411 224 416 0 0 0 0 0 0 0
Totale 3.647